$FBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Fortress Biotech, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Fortress Biotech, Inc.. Get notifications about new insider transactions in Fortress Biotech, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 09 2021 | FBIO | Fortress Biotech, ... | WEISS MICHAEL S | See Remarks | Grant | A | 0.00 | 1,030,339 | 0 | 11,232,150 | 10.2 M to 11.2 M (+10.10 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 4.45 | 10,000 | 44,500 | 720,000 | 730 K to 720 K (-1.37 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 4.31 | 8,000 | 34,480 | 730,000 | 738 K to 730 K (-1.08 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 4.20 | 6,000 | 25,200 | 738,000 | 744 K to 738 K (-0.81 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 3.86 | 2,000 | 7,720 | 744,000 | 746 K to 744 K (-0.27 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 3.80 | 4,000 | 15,200 | 746,000 | 750 K to 746 K (-0.53 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 750,000 | 650 K to 750 K (+15.38 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CH ... | Grant | A | 0.00 | 1,030,339 | 0 | 10,407,039 | 9.4 M to 10.4 M (+10.99 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CH ... | Grant | A | 2.34 | 1,250 | 2,925 | 9,376,700 | 9.4 M to 9.4 M (+0.01 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CH ... | Grant | A | 1.69 | 1,602 | 2,707 | 9,375,450 | 9.4 M to 9.4 M (+0.02 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Lorenz Kevin | Director | Buy | P | 0.00 | 50,000 | 0 | 214,582 | 164.6 K to 214.6 K (+30.38 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | LOBELL J JAY | Director | Grant | A | 0.00 | 100,000 | 0 | 1,136,000 | 1 M to 1.1 M (+9.65 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Grant | A | 0.00 | 100,000 | 0 | 655,000 | 555 K to 655 K (+18.02 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Hoenlein Malcolm | Director | Grant | A | 0.00 | 50,000 | 0 | 435,000 | 385 K to 435 K (+12.99 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Harvey Jimmie | Director | Grant | A | 0.00 | 100,000 | 0 | 750,000 | 650 K to 750 K (+15.38 %) |
Sep 25 2020 | FBIO | Fortress Biotech, ... | Hunter Robyn | Chief Financial Off ... | Sell | S | 4.38 | 28,450 | 124,611 | 192,169 | 220.6 K to 192.2 K (-12.90 %) |
Sep 01 2020 | FBIO | Fortress Biotech, ... | Hoenlein Malcolm | Director | Buy | P | 18.00 | 16,667 | 300,006 | 16,667 | 0 to 16.7 K |
Sep 01 2020 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CH ... | Buy | P | 18.00 | 52,500 | 945,000 | 92,500 | 40 K to 92.5 K (+131.25 %) |
Mar 13 2020 | FBIO | Fortress Biotech, ... | WEISS MICHAEL S | EXECUTIVE VICE CHAI ... | Grant | A | 0.00 | 801,536 | 0 | 10,201,811 | 9.4 M to 10.2 M (+8.53 %) |
Mar 13 2020 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 650,000 | 550 K to 650 K (+18.18 %) |
Mar 13 2020 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CH ... | Grant | A | 0.00 | 801,536 | 0 | 9,373,848 | 8.6 M to 9.4 M (+9.35 %) |
Mar 13 2020 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CH ... | Buy | P | 2.06 | 1,123 | 2,313 | 8,572,312 | 8.6 M to 8.6 M (+0.01 %) |
Mar 13 2020 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CH ... | Buy | P | 1.10 | 1,467 | 1,614 | 8,571,189 | 8.6 M to 8.6 M (+0.02 %) |
Mar 13 2020 | FBIO | Fortress Biotech, ... | Lorenz Kevin | Director | Buy | P | 0.00 | 50,000 | 0 | 164,582 | 114.6 K to 164.6 K (+43.64 %) |
Mar 13 2020 | FBIO | Fortress Biotech, ... | LOBELL J JAY | Director | Grant | A | 0.00 | 100,000 | 0 | 1,036,000 | 936 K to 1 M (+10.68 %) |
Mar 13 2020 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Grant | A | 0.00 | 100,000 | 0 | 555,000 | 455 K to 555 K (+21.98 %) |
Mar 13 2020 | FBIO | Fortress Biotech, ... | Hoenlein Malcolm | Director | Grant | A | 0.00 | 50,000 | 0 | 385,000 | 335 K to 385 K (+14.93 %) |
Mar 13 2020 | FBIO | Fortress Biotech, ... | Harvey Jimmie | Director | Grant | A | 0.00 | 100,000 | 0 | 650,000 | 550 K to 650 K (+18.18 %) |
Dec 31 2019 | FBIO | Fortress Biotech, ... | Hunter Robyn | Chief Financial Off ... | Buy | P | 1.10 | 2,297 | 2,527 | 220,619 | 218.3 K to 220.6 K (+1.05 %) |
Jul 19 2019 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CH ... | Grant | A | 1.26 | 396,825 | 500,000 | 8,569,722 | 8.2 M to 8.6 M (+4.86 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | WEISS MICHAEL S | EXECUTIVE VICE CHAI ... | Grant | A | 0.00 | 648,204 | 0 | 9,400,275 | 8.8 M to 9.4 M (+7.41 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | WEISS MICHAEL S | EXECUTIVE VICE CHAI ... | Grant | A | 0.00 | 164,473 | 0 | 8,752,071 | 8.6 M to 8.8 M (+1.92 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | WEISS MICHAEL S | EXECUTIVE VICE CHAI ... | Grant | A | 0.00 | 586,428 | 0 | 8,587,598 | 8 M to 8.6 M (+7.33 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Grant | A | 0.00 | 100,000 | 0 | 455,000 | 355 K to 455 K (+28.17 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Grant | A | 0.00 | 100,000 | 0 | 355,000 | 255 K to 355 K (+39.22 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT AND CEO | Grant | A | 0.00 | 648,204 | 0 | 8,172,897 | 7.5 M to 8.2 M (+8.61 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT AND CEO | Grant | A | 0.00 | 1,514 | 0 | 7,524,693 | 7.5 M to 7.5 M (+0.02 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT AND CEO | Grant | A | 0.00 | 164,473 | 0 | 7,523,179 | 7.4 M to 7.5 M (+2.24 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT AND CEO | Grant | A | 0.00 | 586,428 | 0 | 7,358,706 | 6.8 M to 7.4 M (+8.66 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | LOBELL J JAY | Director | Grant | A | 0.00 | 100,000 | 0 | 936,000 | 836 K to 936 K (+11.96 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | Hoenlein Malcolm | Director | Grant | A | 0.00 | 50,000 | 0 | 335,000 | 285 K to 335 K (+17.54 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | Harvey Jimmie | Director | Grant | A | 0.00 | 100,000 | 0 | 550,000 | 450 K to 550 K (+22.22 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 550,000 | 450 K to 550 K (+22.22 %) |
Dec 13 2018 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, BIOLOGICS OPER ... | Sell | S | 1.05 | 97,325 | 102,191 | 255,170 | 352.5 K to 255.2 K (-27.61 %) |
Nov 30 2018 | FBIO | Fortress Biotech, ... | Hoenlein Malcolm | Director | Grant | A | 0.00 | 50,000 | 0 | 285,000 | 235 K to 285 K (+21.28 %) |
Nov 30 2018 | FBIO | Fortress Biotech, ... | Harvey Jimmie | Director | Grant | A | 0.00 | 100,000 | 0 | 450,000 | 350 K to 450 K (+28.57 %) |
Nov 30 2018 | FBIO | Fortress Biotech, ... | LOBELL J JAY | Director | Grant | A | 0.00 | 100,000 | 0 | 786,000 | 686 K to 786 K (+14.58 %) |
Nov 30 2018 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 450,000 | 350 K to 450 K (+28.57 %) |
Nov 30 2018 | FBIO | Fortress Biotech, ... | Hunter Robyn | Chief Financial Off ... | Sell | S | 1.29 | 20,370 | 26,277 | 239,759 | 260.1 K to 239.8 K (-7.83 %) |
Dec 18 2017 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, BIOLOGICS OPER ... | Sell | S | 3.55 | 12,000 | 42,600 | 352,495 | 364.5 K to 352.5 K (-3.29 %) |
Dec 14 2017 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, BIOLOGICS OPER ... | Sell | S | 3.57 | 19,000 | 67,830 | 364,495 | 383.5 K to 364.5 K (-4.95 %) |
Dec 14 2017 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, BIOLOGICS OPER ... | Sell | S | 3.59 | 25,593 | 91,879 | 383,495 | 409.1 K to 383.5 K (-6.26 %) |
Dec 14 2017 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, BIOLOGICS OPER ... | Grant | A | 0.00 | 150,000 | 0 | 409,088 | 259.1 K to 409.1 K (+57.90 %) |
Nov 08 2017 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | PRESIDENT, CEO | Buy | P | 25.00 | 40,000 | 1,000,000 | 40,000 | 0 to 40 K |
Jul 21 2017 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Option Exercise | A | 0.00 | 13,333 | 0 | 53,332 | |
Jul 21 2017 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Sell | D | 0.00 | 13,333 | 0 | 201,668 | 215 K to 201.7 K (-6.20 %) |
Jul 21 2017 | FBIO | Fortress Biotech, ... | Hoenlein Malcolm | Director | Option Exercise | A | 0.00 | 16,666 | 0 | 49,998 | |
Jul 21 2017 | FBIO | Fortress Biotech, ... | Harvey Jimmie | Director | Option Exercise | A | 0.00 | 16,666 | 0 | 49,998 | |
Jul 21 2017 | FBIO | Fortress Biotech, ... | Harvey Jimmie | Director | Option Exercise | A | 0.00 | 16,666 | 0 | 49,998 | |
Jun 07 2017 | FBIO | Fortress Biotech, ... | Fortress Biotech, Inc. | 10% Owner | Grant | A | 0.00 | 1,600 | 0 | 10,132,653 | 10.1 M to 10.1 M (+0.02 %) |
Jun 07 2017 | FBIO | Fortress Biotech, ... | Fortress Biotech, Inc. | 10% Owner | Grant | A | 0.00 | 767,264 | 0 | 10,131,053 | 9.4 M to 10.1 M (+8.19 %) |
Jun 07 2017 | FBIO | Fortress Biotech, ... | Fortress Biotech, Inc. | 10% Owner | Grant | A | 0.00 | 213,419 | 0 | 9,363,789 | 9.2 M to 9.4 M (+2.33 %) |
Jun 07 2017 | FBIO | Fortress Biotech, ... | Fortress Biotech, Inc. | 10% Owner | Grant | A | 0.00 | 15,806 | 0 | 9,150,370 | 9.1 M to 9.2 M (+0.17 %) |
Jun 07 2017 | FBIO | Fortress Biotech, ... | Fortress Biotech, Inc. | 10% Owner | Grant | A | 0.00 | 11,925 | 0 | 9,134,564 | 9.1 M to 9.1 M (+0.13 %) |
Jun 07 2017 | FBIO | Fortress Biotech, ... | Fortress Biotech, Inc. | 10% Owner | Grant | A | 0.00 | 47,505 | 0 | 9,122,639 | 9.1 M to 9.1 M (+0.52 %) |
Jun 07 2017 | FBIO | Fortress Biotech, ... | Fortress Biotech, Inc. | 10% Owner | Grant | A | 0.00 | 27,264 | 0 | 9,075,134 | 9 M to 9.1 M (+0.30 %) |
Jun 07 2017 | FBIO | Fortress Biotech, ... | Fortress Biotech, Inc. | 10% Owner | Grant | A | 0.00 | 47,870 | 0 | 9,047,870 | 9 M to 9 M (+0.53 %) |
Jun 07 2017 | FBIO | Fortress Biotech, ... | Fortress Biotech, Inc. | 10% Owner | Grant | A | 0.00 | 721,699 | 0 | 2,702,705 | 2 M to 2.7 M (+36.43 %) |
Jan 27 2017 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | President and CEO | Grant | A | 0.00 | 552,698 | 0 | 5,857,168 | 5.3 M to 5.9 M (+10.42 %) |
Jan 27 2017 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | President and CEO | Buy | P | 2.03 | 731 | 1,484 | 5,304,470 | 5.3 M to 5.3 M (+0.01 %) |
Jan 24 2017 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Option Exercise | A | 0.00 | 26,666 | 0 | 39,999 | |
Jan 24 2017 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Sell | D | 0.00 | 26,666 | 0 | 215,001 | 241.7 K to 215 K (-11.03 %) |
Jan 24 2017 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Grant | A | 0.00 | 100,000 | 0 | 241,667 | 141.7 K to 241.7 K (+70.59 %) |
Jan 24 2017 | FBIO | Fortress Biotech, ... | Hoenlein Malcolm | Director | Option Exercise | A | 0.00 | 16,666 | 0 | 33,332 | |
Jan 24 2017 | FBIO | Fortress Biotech, ... | Harvey Jimmie | Director | Option Exercise | A | 0.00 | 16,666 | 0 | 33,332 | |
Jan 24 2017 | FBIO | Fortress Biotech, ... | Harvey Jimmie | Director | Option Exercise | A | 0.00 | 16,666 | 0 | 33,332 | |
Jan 24 2017 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 350,000 | 250 K to 350 K (+40.00 %) |
Jan 24 2017 | FBIO | Fortress Biotech, ... | LOBELL J JAY | Director | Grant | A | 0.00 | 100,000 | 0 | 686,000 | 586 K to 686 K (+17.06 %) |
Sep 19 2016 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | S | 2.55 | 33,912 | 86,476 | 259,088 | 293 K to 259.1 K (-11.57 %) |
Sep 19 2016 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | S | 2.54 | 15,000 | 38,100 | 293,000 | 308 K to 293 K (-4.87 %) |
Sep 16 2016 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Grant | A | 0.00 | 150,000 | 0 | 308,000 | 158 K to 308 K (+94.94 %) |
Jul 19 2016 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Option Exercise | A | 0.00 | 13,333 | 0 | 13,333 | |
Jul 19 2016 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Sell | D | 0.00 | 13,333 | 0 | 141,667 | 155 K to 141.7 K (-8.60 %) |
Jun 17 2016 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | President and CEO | Buy | P | 2.40 | 613 | 1,471 | 5,303,739 | 5.3 M to 5.3 M (+0.01 %) |
May 23 2016 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | Co-Chairman and CEO | Sell | S | 0.00 | 1,020,000 | 0 | 265,000 | 1.3 M to 265 K (-79.38 %) |
Mar 28 2016 | FBIO | Fortress Biotech, ... | Harvey Jimmie | Director | Option Exercise | A | 0.00 | 16,666 | 0 | 16,666 | |
Mar 28 2016 | FBIO | Fortress Biotech, ... | Harvey Jimmie | Director | Option Exercise | A | 0.00 | 16,666 | 0 | 16,666 | |
Mar 28 2016 | FBIO | Fortress Biotech, ... | Hoenlein Malcolm | Director | Option Exercise | A | 0.00 | 16,666 | 0 | 16,666 | |
Mar 18 2016 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | Co-Chairman and CEO | Option Exercise | A | 10.00 | 7,500 | 75,000 | 32,500 | |
Feb 04 2016 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | Co-Chairman and CEO | Option Exercise | A | 10.00 | 10,000 | 100,000 | 25,000 | |
Jan 05 2016 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Grant | A | 0.00 | 100,000 | 0 | 155,000 | 55 K to 155 K (+181.82 %) |
Jan 05 2016 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | President and CEO | Grant | A | 0.00 | 510,434 | 0 | 5,303,126 | 4.8 M to 5.3 M (+10.65 %) |
Jan 05 2016 | FBIO | Fortress Biotech, ... | WEISS MICHAEL S | Exec. VC - Strategi ... | Grant | A | 0.00 | 510,434 | 0 | 7,448,472 | 6.9 M to 7.4 M (+7.36 %) |
Jan 05 2016 | FBIO | Fortress Biotech, ... | LOBELL J JAY | Director | Grant | A | 0.00 | 100,000 | 0 | 586,000 | 486 K to 586 K (+20.58 %) |
Jan 05 2016 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 250,000 | 150 K to 250 K (+66.67 %) |
Dec 09 2015 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | President and CEO | Buy | P | 2.41 | 586 | 1,412 | 4,792,692 | 4.8 M to 4.8 M (+0.01 %) |
Oct 13 2015 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | Co-Chairman and CEO | Option Exercise | A | 10.00 | 50,000 | 500,000 | 15,000 | |
Sep 14 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | D | 2.68 | 31,299 | 83,900 | 158,000 | 189.3 K to 158 K (-16.53 %) |
Sep 14 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | D | 2.62 | 22,737 | 59,555 | 189,299 | 212 K to 189.3 K (-10.72 %) |
Sep 10 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | D | 2.62 | 14,100 | 36,941 | 212,036 | 226.1 K to 212 K (-6.24 %) |
Sep 10 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | D | 2.57 | 11,704 | 30,102 | 226,136 | 237.8 K to 226.1 K (-4.92 %) |
Sep 08 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | D | 2.60 | 2,136 | 5,554 | 237,840 | 240 K to 237.8 K (-0.89 %) |
Sep 04 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | D | 2.58 | 18,200 | 47,029 | 239,976 | 258.2 K to 240 K (-7.05 %) |
Sep 04 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | D | 2.60 | 24,900 | 64,690 | 258,176 | 283.1 K to 258.2 K (-8.80 %) |
Sep 03 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | D | 2.70 | 158 | 427 | 283,076 | 283.2 K to 283.1 K (-0.06 %) |
Sep 02 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | D | 2.94 | 3,500 | 10,295 | 283,234 | 286.7 K to 283.2 K (-1.22 %) |
Aug 25 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | D | 2.55 | 10,000 | 25,458 | 286,734 | 296.7 K to 286.7 K (-3.37 %) |
Aug 21 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Sell | D | 3.00 | 11,266 | 33,798 | 296,734 | 308 K to 296.7 K (-3.66 %) |
Aug 14 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Grant | A | 0.00 | 300,000 | 0 | 308,000 | 8 K to 308 K (+3,750.00 %) |
Jul 17 2015 | FBIO | Fortress Biotech, ... | Avgerinos George | SVP, Biologics Oper ... | Option Exercise | D | 9.21 | 200,000 | 1,842,000 | 0 | |
Jul 17 2015 | FBIO | Fortress Biotech, ... | Klein Dov | Director | Grant | A | 0.00 | 50,000 | 0 | 55,000 | 5 K to 55 K (+1,000.00 %) |
Jun 03 2015 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | President and CEO | Buy | P | 1.80 | 785 | 1,413 | 4,792,106 | 4.8 M to 4.8 M (+0.02 %) |
Mar 20 2015 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | Co-Chairman and CEO | Option Exercise | A | 10.00 | 10,000 | 100,000 | 10,000 | |
Mar 16 2015 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 50,000 | 0 | 150,000 | 100 K to 150 K (+50.00 %) |
Mar 16 2015 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 50,000 | 0 | 100,000 | 50 K to 100 K (+100.00 %) |
Mar 16 2015 | FBIO | Fortress Biotech, ... | LOBELL J JAY | Director | Grant | A | 0.00 | 50,000 | 0 | 486,000 | 436 K to 486 K (+11.47 %) |
Mar 16 2015 | FBIO | Fortress Biotech, ... | LOBELL J JAY | Director | Grant | A | 0.00 | 50,000 | 0 | 436,000 | 386 K to 436 K (+12.95 %) |
Jan 06 2015 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | Co-Chairman and CEO | Sell | J | 0.00 | 100,000 | 0 | 1,285,000 | 1.4 M to 1.3 M (-7.22 %) |
Dec 03 2014 | FBIO | Fortress Biotech, ... | Lu Lucy | Chief Financial Off ... | Buy | P | 1.45 | 5,000 | 7,250 | 35,631 | 30.6 K to 35.6 K (+16.32 %) |
Dec 03 2014 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | President and CEO | Buy | P | 1.45 | 974 | 1,412 | 4,791,321 | 4.8 M to 4.8 M (+0.02 %) |
Nov 10 2014 | FBIO | Fortress Biotech, ... | WEISS MICHAEL S | Exec. VC - Strategi ... | Buy | P | 1.61 | 1,000,000 | 1,610,000 | 6,938,038 | 5.9 M to 6.9 M (+16.84 %) |
Nov 10 2014 | FBIO | Fortress Biotech, ... | Hoenlein Malcolm | Director | Buy | P | 1.61 | 25,000 | 40,250 | 55,000 | 30 K to 55 K (+83.33 %) |
Nov 10 2014 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | President and CEO | Buy | P | 1.61 | 150,000 | 241,500 | 4,790,347 | 4.6 M to 4.8 M (+3.23 %) |
Jun 04 2014 | FBIO | Fortress Biotech, ... | Lu Lucy | Chief Financial Off ... | Buy | P | 1.37 | 5,000 | 6,850 | 30,631 | 25.6 K to 30.6 K (+19.51 %) |
Apr 23 2014 | FBIO | Fortress Biotech, ... | HORGAN KEVIN | Option Exercise | M | 1.71 | 47,566 | 81,338 | 0 | ||
Apr 23 2014 | FBIO | Fortress Biotech, ... | HORGAN KEVIN | Sell | S | 1.89 | 47,566 | 89,976 | 0 | 47.6 K to 0 (-100.00 %) | |
Apr 23 2014 | FBIO | Fortress Biotech, ... | HORGAN KEVIN | Buy | M | 1.71 | 47,566 | 81,338 | 47,566 | 0 to 47.6 K | |
Apr 22 2014 | FBIO | Fortress Biotech, ... | HORGAN KEVIN | Option Exercise | M | 1.71 | 19,000 | 32,490 | 47,566 | ||
Apr 22 2014 | FBIO | Fortress Biotech, ... | HORGAN KEVIN | Sell | S | 1.81 | 19,000 | 34,382 | 0 | 19 K to 0 (-100.00 %) | |
Apr 22 2014 | FBIO | Fortress Biotech, ... | HORGAN KEVIN | Buy | M | 1.71 | 19,000 | 32,490 | 19,000 | 0 to 19 K | |
Apr 21 2014 | FBIO | Fortress Biotech, ... | HORGAN KEVIN | Option Exercise | M | 1.71 | 101 | 173 | 66,566 | ||
Apr 21 2014 | FBIO | Fortress Biotech, ... | HORGAN KEVIN | Sell | S | 1.85 | 101 | 187 | 0 | 101 to 0 (-100.00 %) | |
Apr 21 2014 | FBIO | Fortress Biotech, ... | HORGAN KEVIN | Buy | M | 1.71 | 101 | 173 | 101 | 0 to 101 | |
Feb 24 2014 | FBIO | Fortress Biotech, ... | BARRETT DAVID JONATHAN | Director | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Feb 24 2014 | FBIO | Fortress Biotech, ... | Harvey Jimmie | Director | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Feb 24 2014 | FBIO | Fortress Biotech, ... | LOBELL J JAY | Director | Grant | A | 0.00 | 50,000 | 0 | 386,000 | 336 K to 386 K (+14.88 %) |
Feb 24 2014 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Feb 24 2014 | FBIO | Fortress Biotech, ... | WEISS MICHAEL S | Exec. VC - Strategi ... | Grant | A | 0.00 | 3,958,692 | 0 | 5,938,038 | 2 M to 5.9 M (+200.00 %) |
Feb 24 2014 | FBIO | Fortress Biotech, ... | Hoenlein Malcolm | Director | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
Jan 17 2014 | FBIO | Fortress Biotech, ... | LOBELL J JAY | Director | Option Exercise | A | 2.10 | 30,000 | 63,000 | 30,000 | |
Jan 07 2014 | FBIO | Fortress Biotech, ... | Lu Lucy | Chief Financial Off ... | Buy | P | 1.39 | 1,107 | 1,539 | 25,631 | 24.5 K to 25.6 K (+4.51 %) |
Dec 23 2013 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Option Exercise | A | 2.10 | 30,000 | 63,000 | 30,000 | |
Dec 23 2013 | FBIO | Fortress Biotech, ... | ROSENWALD LINDSAY A MD | President and CEO | Grant | A | 0.00 | 1,979,346 | 0 | 4,638,347 | 2.7 M to 4.6 M (+74.44 %) |
Dec 23 2013 | FBIO | Fortress Biotech, ... | WEISS MICHAEL S | Director | Option Exercise | A | 2.10 | 30,000 | 63,000 | 30,000 | |
Dec 23 2013 | FBIO | Fortress Biotech, ... | WEISS MICHAEL S | Director | Grant | A | 0.00 | 1,979,346 | 0 | 1,979,346 | 0 to 2 M |
Dec 23 2013 | FBIO | Fortress Biotech, ... | Harvey Jimmie | Director | Option Exercise | A | 2.10 | 30,000 | 63,000 | 30,000 | |
Dec 23 2013 | FBIO | Fortress Biotech, ... | BARRETT DAVID JONATHAN | Director | Option Exercise | A | 2.10 | 30,000 | 63,000 | 30,000 | |
Nov 06 2013 | FBIO | Fortress Biotech, ... | HORGAN KEVIN | Chief Medical Offic ... | Option Exercise | A | 1.71 | 200,000 | 342,000 | 200,000 | |
Aug 22 2013 | FBIO | Fortress Biotech, ... | Lu Lucy | Chief Financial Off ... | Buy | P | 7.38 | 5,000 | 36,900 | 24,524 | 19.5 K to 24.5 K (+25.61 %) |
Aug 22 2013 | FBIO | Fortress Biotech, ... | LOBELL J JAY | Director | Buy | P | 7.37 | 5,000 | 36,850 | 336,000 | 331 K to 336 K (+1.51 %) |